Per capita medicine use compound annual growth rate vs Clinical trial country use share in North America
Per capita medicine use compound annual growth rate and Clinical trial country use share in North America, compared over time.
Change the pair
Compare different indicators
The series
Over time
North America, spaced by time. Both series are in %, so they share one axis; the legend names each line.
Per capita medicine use compound annual growth rate and Clinical trial country use share
Unit: % · 5 observations
Forecast: dashed line, hollow markers, shaded band
View the underlying data
| Indicator | Period | Type | Value |
|---|---|---|---|
| Per capita medicine use compound annual growth rate | 2026–2030 | Forecast | 0.9% |
| Per capita medicine use compound annual growth rate | 2025–2030 | Forecast | 0.9% |
| Per capita medicine use compound annual growth rate | 2020–2025 | Actual | 2.1% |
| Clinical trial country use share | 2023 | Actual | 23% |
| Clinical trial country use share | 2019 | Actual | 19% |
Source: IQVIA · CC BY 4.0 · Per capita medicine use compound annual growth rate · Clinical trial country use share
Provenance
Where these numbers come from
Per capita medicine use compound annual growth rate
Compound annual growth rate of per capita medicine use.
3 observations in North America · source organisations: IQVIA
Clinical trial country use share
Percentage of total clinical trial country uses accounted for by a given region.
2 observations in North America · source organisations: IQVIA
Data published under CC BY 4.0. Series A as JSON · Series B as JSON
Keep exploring